The management of thyroid cancer has been controversial and, as a result, the routine use of imaging in this disease, especially for pre-operative staging, has lagged behind other head and neck cancers. However, as more is known about the natural history of thyroid cancer, the role of imaging is becoming more established. This review focuses on how imaging now influences the staging and management of the primary cancer, nodal metastases and distant metastases. This is followed by a brief review of the role of imaging in planning post-operative radiotherapy and post-treatment surveillance.

Author

Ann D. King

Contact Details

Corresponding address:
Dr A.D. King, Department of Diagnostic Radiology and Organ Imaging, Faculty of Medicine,
The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Reference

ICIS Cancer Imaging Volume 8 Issue 1
DOI: 10.1102/1470-7330.2008.0007

Date Posted

25 March 2008

Print PDF

Size

4.70 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	18 seconds
ADSL 512Kb/s (Broadband):	1 minute 15 seconds
64 Kb/s (ISDN):	10 minutes 1 second
33.3 Kb/s (Typical Modem):	19 minutes 15 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.